Volume 19, Number 3—March 2013
Dispatch
Swine Influenza in Sri Lanka
Table 2
Virus antigen (lineage) | Seroprevalence, no. (%) |
||||
---|---|---|---|---|---|
Jan 2004–Mar 2005, n = 300 | Feb–Aug 2010, n = 149 | Sep 2010–Mar 2011, n = 284 | Apr–Oct 2011, n = 577 | Nov 2011–May 2012, n = 763 | |
A/swine/Colombo/48/2004 (H3N2) (human-like) | 185 (61.6%) | 06 (4.0%) | 0 | 0 | 0 |
A/swine/HK/2422/98 (H3N2) (swine) (human) | 0 | 0 | 0 | 0 | 0 |
A/Sydney/5/97 (H3N2) (human) | 0 | 0 | 0 | 0 | 0 |
A/swine/HK/1774/99 (H3N2) (European swinelike) | 0 | 0 | 0 | 0 | 0 |
A/HK/44062/2011 (H3N2) (human) | Not tested | Not tested | 0 | 0 | 0 |
A/swine/Colombo/330/2009 (H1N1) (H1N1pdm09) | 0 | 16 (10.7) | 95 (33.5) | 14 (25.1) | 77 (10.1) |
A/swine/HK/29/2009 (H1N1) (Eurasian avian) | 0 | 01 (0.6) | 0 | 0 | 0 |
A/swine/HK/1110/2006 (H1N1) (North American–triple reassortant) | 0 | 01 (0.6) | 0 | 0 | 0 |
A/swine/HK/915/2004 (H1N2) (North American–TR) | 0 | 0 | 0 | 0 | 0 |
A/swine/HK/4167/99 (H1N1) (classical swine) | 0 | 0 | 0 | 0 | 0 |
A/swine/Ghent/G112/2007 (Eurasian avian) | 0 | 0 | 0 | 0 | 0 |
*Hemagglutination inhibition reciprocal antibody titers ≥40 were considered positive. The range of the antibody titers was 40 to ≥1,280. If serum reacted to multiple antigenically related influenza H3 or H1 subtype viruses, we categorized the serum as having a homologous reaction profile to the virus to which titer was ≥4-fold higher than that for other viruses of the same subtype. For example, during 2004–2005, some serum samples were seropositive for influenza A/swine/HK/2422/98 (H3N2) virus; however, because in the same sample, titer to influenza A/swine/Colombo/48/2004 (H3N2) virus was >4-fold higher, reactivity was attributed to the latter.
Page created: February 12, 2013
Page updated: February 12, 2013
Page reviewed: February 12, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.